Free Trial

Tempest Therapeutics (TPST) SEC Filings & 10K Form

Tempest Therapeutics logo
$10.57 +0.55 (+5.49%)
Closing price 08/25/2025 04:00 PM Eastern
Extended Trading
$10.80 +0.23 (+2.22%)
As of 08:17 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Tempest Therapeutics SEC Filings

DateFilerForm TypeView
08/13/2025
6:14 PM
Tempest Therapeutics, Inc. (Subject)
Tempest Therapeutics (Subject)
Versant Venture Capital VI, L.P. (Filed by)
Form SCHEDULE 13D/A
06/12/2025
8:01 AM
Tempest Therapeutics, Inc. (Filer)
Tempest Therapeutics (Filer)
Form 424B5
06/11/2025
6:41 AM
Tempest Therapeutics, Inc. (Filer)
Tempest Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2025
3:23 PM
Tempest Therapeutics, Inc. (Filer)
Tempest Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/28/2025
8:49 AM
Tempest Therapeutics, Inc. (Filer)
Tempest Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2025
4:26 PM
Tempest Therapeutics, Inc. (Filer)
Tempest Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/07/2025
7:00 AM
Tempest Therapeutics, Inc. (Filer)
Tempest Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2025
4:12 PM
Tempest Therapeutics, Inc. (Filer)
Tempest Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/27/2025
3:35 PM
Tempest Therapeutics, Inc. (Filer)
Tempest Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/11/2025
4:58 PM
Tempest Therapeutics, Inc. (Subject)
Tempest Therapeutics (Subject)
Versant Venture Capital VI, L.P. (Filed by)
Form SCHEDULE 13D/A
02/06/2025
3:59 PM
Tempest Therapeutics, Inc. (Filer)
Tempest Therapeutics (Filer)
Form 424B5
01/27/2025
11:15 PM
Tempest Therapeutics, Inc. (Filer)
Tempest Therapeutics (Filer)
Form EFFECT
01/24/2025
3:35 PM
Tempest Therapeutics, Inc. (Filer)
Tempest Therapeutics (Filer)
Form S-3/A
12/31/2024
3:01 PM
Tempest Therapeutics, Inc. (Filer)
Tempest Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2024
3:15 PM
Tempest Therapeutics, Inc. (Filer)
Tempest Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2024
3:15 PM
Tempest Therapeutics, Inc. (Filer)
Tempest Therapeutics (Filer)
Form PRE 14A
10/10/2024
6:30 AM
Tempest Therapeutics, Inc. (Filer)
Tempest Therapeutics (Filer)
Form 8-A12B/A
10/10/2024
6:16 AM
Tempest Therapeutics, Inc. (Filer)
Tempest Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:TPST) was last updated on 8/26/2025 by MarketBeat.com Staff
From Our Partners